ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,006Medicare Part D Prescriptions Filled, Including Refills

Rank: 178 out of 1844

$470K Total Retail Price of All Prescriptions

Rank: 410 out of 1844

401 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 401 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 401 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

0% of this provider’s 9,329 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 466 403 1 1
HYDROCODONE-ACETAMINOPHEN 367 352 S3 2 2
SIMVASTATIN 366 301 3 3
OMEPRAZOLE 333 276 4 5
LISINOPRIL 328 267 5 4
METFORMIN HCL 299 210 6 8
FUROSEMIDE 279 249 7 7
ALBUTEROL SULFATE 258 258 8 115
AMLODIPINE BESYLATE 247 242 9 6
POLYETHYLENE GLYCOL 3350 236 226 10 39
DONEPEZIL HCL 189 176 11 26
GABAPENTIN 188 144 12 15
WARFARIN SODIUM 179 166 13 13
TRAZODONE HCL 178 150 14 43
CITALOPRAM HBR 177 127 15 19
RISPERIDONE 143 143 16 65
SERTRALINE HCL 141 118 17 21
TRAMADOL HCL 137 117 18 18
IPRATROPIUM BROMIDE 129 129 19 198
ESCITALOPRAM OXALATE 128 118 20 52
FENTANYL 125 117 S2 21 66
LOSARTAN POTASSIUM 124 122 22 24
HYDROCHLOROTHIAZIDE 114 102 23 9
FLUTICASONE PROPIONATE 113 104 24 50
NAMENDA 111 99 25 33
PANTOPRAZOLE SODIUM 108 98 26 32
ATENOLOL 103 93 27 17
METOPROLOL TARTRATE 98 97 28 11
CARBIDOPA-LEVODOPA 97 83 29 86
METOPROLOL SUCCINATE 95 84 30 14
PRAVASTATIN SODIUM 94 75 31 10
PREDNISONE 94 89 31 40
MIRTAZAPINE 89 73 33 49
FLUOXETINE HCL 85 77 34 41
LANTUS 85 68 34 42
TRIAMCINOLONE ACETONIDE 78 74 36 153
TAMSULOSIN HCL 77 65 37 27
DIVALPROEX SODIUM 75 36 38 74
ATORVASTATIN CALCIUM 75 65 38 12
CEPHALEXIN 73 70 40 56
ADVAIR DISKUS 72 66 41 51
QUETIAPINE FUMARATE 72 72 41 82
CARVEDILOL 70 62 43 22
ALLOPURINOL 70 70 43 29
PAROXETINE HCL 67 67 45 68
ZOLPIDEM TARTRATE 66 62 46 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 63 47 20
OLANZAPINE 63 38 48 117
GLIMEPIRIDE 61 43 49 35
CLOPIDOGREL 60 54 50 34
KLOR-CON M20 58 40 51 54
DIGOXIN 58 57 51 67
ALENDRONATE SODIUM 55 55 53 25
BUPROPION XL 52 52 54 190
POTASSIUM CHLORIDE 52 31 54 16
FAMOTIDINE 50 50 56 63
LOPERAMIDE 50 0 56 216
BUPROPION HCL SR 50 50 56 196
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.